Renal Dose Adjustment for Aztreonam
For an 87-year-old female with serum creatinine 2.03 mg/dL on aztreonam, calculate her creatinine clearance first, then adjust the dose accordingly: give a loading dose of 1-2g IV, followed by maintenance doses that are halved if CrCl is 10-30 mL/min, or reduced to one-fourth the usual dose if CrCl is <10 mL/min. 1
Step 1: Calculate Creatinine Clearance
Using the Cockcroft-Gault equation for females 1:
CrCl = 0.85 × [(140 - age) × weight (kg)] / [72 × serum creatinine (mg/dL)]
For this 87-year-old female with creatinine 2.03 mg/dL, assuming a typical weight of 60 kg:
- CrCl = 0.85 × [(140 - 87) × 60] / [72 × 2.03]
- CrCl ≈ 18.5 mL/min
This places her in the severe renal impairment category (CrCl 10-30 mL/min).
Step 2: Dosing Recommendations Based on Renal Function
For CrCl 10-30 mL/min 1:
- Loading dose: Give the usual initial dose of 1g or 2g IV (depending on infection severity)
- Maintenance dose: Halve the usual dose and give at the usual interval (q6h, q8h, or q12h)
- Example: If usual dose is 2g q8h → give 1g q8h
- Example: If usual dose is 1g q8h → give 500mg q8h
Alternative Approach from Research Evidence:
The pharmacokinetic studies support that aztreonam clearance correlates directly with creatinine clearance 2, 3. With a CrCl of approximately 18.5 mL/min, her aztreonam elimination half-life will be prolonged from the normal 1.7 hours to approximately 4-5 hours 2.
Step 3: Infection Severity Considerations
For moderate infections 1:
- Loading: 1g IV
- Maintenance: 500mg IV q8h
For severe/life-threatening infections 1:
- Loading: 2g IV
- Maintenance: 1g IV q8h
Important Clinical Caveats
Elderly-Specific Considerations:
- Serum creatinine may underestimate renal dysfunction in elderly patients with low muscle mass 1, 4
- The calculated CrCl of 18.5 mL/min may actually represent worse renal function than apparent
- Monitor renal function closely during therapy 1
Safety Profile in Renal Impairment:
- Aztreonam is safe in elderly patients with renal insufficiency 5, 6
- The inactive metabolite SQ 26,992 accumulates with repeated dosing in renal impairment but has not been associated with toxicity 5
- No dose adjustment needed for hepatic impairment 1
Monitoring Parameters:
- Check serum creatinine every 2-3 days initially
- Adjust doses if renal function changes
- Watch for signs of drug accumulation (though aztreonam is well-tolerated even with accumulation)
If She Requires Hemodialysis:
Should her renal function deteriorate further (CrCl <10 mL/min) or if she's on hemodialysis 1:
- Loading: 1-2g IV (usual dose)
- Maintenance: One-fourth of usual dose at usual intervals
- Give 1/8 of initial dose after each hemodialysis session
The key principle: Always give a full loading dose regardless of renal function, then reduce maintenance doses based on calculated creatinine clearance. 1, 2, 3